 | • レポートコード：MRC2-11QY13420 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は創傷生物製剤のグローバル市場について調査・分析したレポートです。種類別（代用皮膚、成長因子）市場規模、用途別（病院、ドラッグストア、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別創傷生物製剤の競争状況、市場シェア ・世界の創傷生物製剤市場：種類別市場規模 2015年-2020年（代用皮膚、成長因子） ・世界の創傷生物製剤市場：種類別市場規模予測 2021年-2026年（代用皮膚、成長因子） ・世界の創傷生物製剤市場：用途別市場規模 2015年-2020年（病院、ドラッグストア、その他） ・世界の創傷生物製剤市場：用途別市場規模予測 2021年-2026年（病院、ドラッグストア、その他） ・北米の創傷生物製剤市場分析：米国、カナダ ・ヨーロッパの創傷生物製剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの創傷生物製剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の創傷生物製剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの創傷生物製剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Avita Medical、ConvaTec、Acelity、Cytori Therapeutic、MacroCure、Nuo Therapeutics、Molyncke Health Care、Osiris Therapeutics、Smith And Nephew、Organogenesis ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The wound healing is a complex process that involves the activation and synchronization of intracellular, and extracellular elements. Wound is healed with tissue regeneration and scar formation. Wound biologic healing helps in re-establishment of the natural repair mechanisms, which includes the application of active biological agents, such as plant-derived active biomolecules which reveal antioxidant, antimicrobial, or anti-inflammatory attributes.
Among the geographies, North America is expected to be the largest market for wound biologics followed by Europe. growing occurrence of chronic diseases and rising demand for recombinant factors are likely to propel the growth in this region. While, Asia-Pacific is expected to grow fast during the forecast period owing to high prevalence of diabetic patients in Asian countries.
Market Analysis and Insights: Global Wound Biologics Market
The global Wound Biologics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Wound Biologics Scope and Market Size
Wound Biologics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Wound Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Wound Biologics market is segmented into
Skin Substitutes
Growth Factors
Segment by Application, the Wound Biologics market is segmented into
Hospital
Drugstore
Others
Regional and Country-level Analysis
The Wound Biologics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Wound Biologics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Wound Biologics Market Share Analysis
Wound Biologics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Wound Biologics business, the date to enter into the Wound Biologics market, Wound Biologics product introduction, recent developments, etc.
The major vendors covered:
Avita Medical
ConvaTec
Acelity
Cytori Therapeutic
MacroCure
Nuo Therapeutics
Molyncke Health Care
Osiris Therapeutics
Smith And Nephew
Organogenesis
1 Study Coverage
1.1 Wound Biologics Product Introduction
1.2 Market Segments
1.3 Key Wound Biologics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Wound Biologics Market Size Growth Rate by Type
1.4.2 Skin Substitutes
1.4.3 Growth Factors
1.5 Market by Application
1.5.1 Global Wound Biologics Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Drugstore
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Wound Biologics Market Size, Estimates and Forecasts
2.1.1 Global Wound Biologics Revenue 2015-2026
2.1.2 Global Wound Biologics Sales 2015-2026
2.2 Global Wound Biologics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Wound Biologics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Wound Biologics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Wound Biologics Competitor Landscape by Players
3.1 Wound Biologics Sales by Manufacturers
3.1.1 Wound Biologics Sales by Manufacturers (2015-2020)
3.1.2 Wound Biologics Sales Market Share by Manufacturers (2015-2020)
3.2 Wound Biologics Revenue by Manufacturers
3.2.1 Wound Biologics Revenue by Manufacturers (2015-2020)
3.2.2 Wound Biologics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Wound Biologics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Wound Biologics Revenue in 2019
3.2.5 Global Wound Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Wound Biologics Price by Manufacturers
3.4 Wound Biologics Manufacturing Base Distribution, Product Types
3.4.1 Wound Biologics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Wound Biologics Product Type
3.4.3 Date of International Manufacturers Enter into Wound Biologics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Wound Biologics Market Size by Type (2015-2020)
4.1.1 Global Wound Biologics Sales by Type (2015-2020)
4.1.2 Global Wound Biologics Revenue by Type (2015-2020)
4.1.3 Wound Biologics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Wound Biologics Market Size Forecast by Type (2021-2026)
4.2.1 Global Wound Biologics Sales Forecast by Type (2021-2026)
4.2.2 Global Wound Biologics Revenue Forecast by Type (2021-2026)
4.2.3 Wound Biologics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Wound Biologics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Wound Biologics Market Size by Application (2015-2020)
5.1.1 Global Wound Biologics Sales by Application (2015-2020)
5.1.2 Global Wound Biologics Revenue by Application (2015-2020)
5.1.3 Wound Biologics Price by Application (2015-2020)
5.2 Wound Biologics Market Size Forecast by Application (2021-2026)
5.2.1 Global Wound Biologics Sales Forecast by Application (2021-2026)
5.2.2 Global Wound Biologics Revenue Forecast by Application (2021-2026)
5.2.3 Global Wound Biologics Price Forecast by Application (2021-2026)
6 North America
6.1 North America Wound Biologics by Country
6.1.1 North America Wound Biologics Sales by Country
6.1.2 North America Wound Biologics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Wound Biologics Market Facts & Figures by Type
6.3 North America Wound Biologics Market Facts & Figures by Application
7 Europe
7.1 Europe Wound Biologics by Country
7.1.1 Europe Wound Biologics Sales by Country
7.1.2 Europe Wound Biologics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Wound Biologics Market Facts & Figures by Type
7.3 Europe Wound Biologics Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Wound Biologics by Region
8.1.1 Asia Pacific Wound Biologics Sales by Region
8.1.2 Asia Pacific Wound Biologics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Wound Biologics Market Facts & Figures by Type
8.3 Asia Pacific Wound Biologics Market Facts & Figures by Application
9 Latin America
9.1 Latin America Wound Biologics by Country
9.1.1 Latin America Wound Biologics Sales by Country
9.1.2 Latin America Wound Biologics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Wound Biologics Market Facts & Figures by Type
9.3 Central & South America Wound Biologics Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Wound Biologics by Country
10.1.1 Middle East and Africa Wound Biologics Sales by Country
10.1.2 Middle East and Africa Wound Biologics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Wound Biologics Market Facts & Figures by Type
10.3 Middle East and Africa Wound Biologics Market Facts & Figures by Application
11 Company Profiles
11.1 Avita Medical
11.1.1 Avita Medical Corporation Information
11.1.2 Avita Medical Description and Business Overview
11.1.3 Avita Medical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Avita Medical Wound Biologics Products Offered
11.1.5 Avita Medical Related Developments
11.2 ConvaTec
11.2.1 ConvaTec Corporation Information
11.2.2 ConvaTec Description and Business Overview
11.2.3 ConvaTec Sales, Revenue and Gross Margin (2015-2020)
11.2.4 ConvaTec Wound Biologics Products Offered
11.2.5 ConvaTec Related Developments
11.3 Acelity
11.3.1 Acelity Corporation Information
11.3.2 Acelity Description and Business Overview
11.3.3 Acelity Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Acelity Wound Biologics Products Offered
11.3.5 Acelity Related Developments
11.4 Cytori Therapeutic
11.4.1 Cytori Therapeutic Corporation Information
11.4.2 Cytori Therapeutic Description and Business Overview
11.4.3 Cytori Therapeutic Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Cytori Therapeutic Wound Biologics Products Offered
11.4.5 Cytori Therapeutic Related Developments
11.5 MacroCure
11.5.1 MacroCure Corporation Information
11.5.2 MacroCure Description and Business Overview
11.5.3 MacroCure Sales, Revenue and Gross Margin (2015-2020)
11.5.4 MacroCure Wound Biologics Products Offered
11.5.5 MacroCure Related Developments
11.6 Nuo Therapeutics
11.6.1 Nuo Therapeutics Corporation Information
11.6.2 Nuo Therapeutics Description and Business Overview
11.6.3 Nuo Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Nuo Therapeutics Wound Biologics Products Offered
11.6.5 Nuo Therapeutics Related Developments
11.7 Molyncke Health Care
11.7.1 Molyncke Health Care Corporation Information
11.7.2 Molyncke Health Care Description and Business Overview
11.7.3 Molyncke Health Care Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Molyncke Health Care Wound Biologics Products Offered
11.7.5 Molyncke Health Care Related Developments
11.8 Osiris Therapeutics
11.8.1 Osiris Therapeutics Corporation Information
11.8.2 Osiris Therapeutics Description and Business Overview
11.8.3 Osiris Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Osiris Therapeutics Wound Biologics Products Offered
11.8.5 Osiris Therapeutics Related Developments
11.9 Smith And Nephew
11.9.1 Smith And Nephew Corporation Information
11.9.2 Smith And Nephew Description and Business Overview
11.9.3 Smith And Nephew Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Smith And Nephew Wound Biologics Products Offered
11.9.5 Smith And Nephew Related Developments
11.10 Organogenesis
11.10.1 Organogenesis Corporation Information
11.10.2 Organogenesis Description and Business Overview
11.10.3 Organogenesis Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Organogenesis Wound Biologics Products Offered
11.10.5 Organogenesis Related Developments
11.1 Avita Medical
11.1.1 Avita Medical Corporation Information
11.1.2 Avita Medical Description and Business Overview
11.1.3 Avita Medical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Avita Medical Wound Biologics Products Offered
11.1.5 Avita Medical Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Wound Biologics Market Estimates and Projections by Region
12.1.1 Global Wound Biologics Sales Forecast by Regions 2021-2026
12.1.2 Global Wound Biologics Revenue Forecast by Regions 2021-2026
12.2 North America Wound Biologics Market Size Forecast (2021-2026)
12.2.1 North America: Wound Biologics Sales Forecast (2021-2026)
12.2.2 North America: Wound Biologics Revenue Forecast (2021-2026)
12.2.3 North America: Wound Biologics Market Size Forecast by Country (2021-2026)
12.3 Europe Wound Biologics Market Size Forecast (2021-2026)
12.3.1 Europe: Wound Biologics Sales Forecast (2021-2026)
12.3.2 Europe: Wound Biologics Revenue Forecast (2021-2026)
12.3.3 Europe: Wound Biologics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Wound Biologics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Wound Biologics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Wound Biologics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Wound Biologics Market Size Forecast by Region (2021-2026)
12.5 Latin America Wound Biologics Market Size Forecast (2021-2026)
12.5.1 Latin America: Wound Biologics Sales Forecast (2021-2026)
12.5.2 Latin America: Wound Biologics Revenue Forecast (2021-2026)
12.5.3 Latin America: Wound Biologics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Wound Biologics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Wound Biologics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Wound Biologics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Wound Biologics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Wound Biologics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Wound Biologics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Wound Biologics Market Segments
Table 2. Ranking of Global Top Wound Biologics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Wound Biologics Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Skin Substitutes
Table 5. Major Manufacturers of Growth Factors
Table 6. Global Wound Biologics Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Wound Biologics Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Wound Biologics Sales by Regions 2015-2020 (K MT)
Table 9. Global Wound Biologics Sales Market Share by Regions (2015-2020)
Table 10. Global Wound Biologics Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Wound Biologics Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Wound Biologics Sales Share by Manufacturers (2015-2020)
Table 13. Global Wound Biologics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Wound Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Wound Biologics as of 2019)
Table 15. Wound Biologics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Wound Biologics Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Wound Biologics Price (2015-2020) (USD/MT)
Table 18. Wound Biologics Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Wound Biologics Product Type
Table 20. Date of International Manufacturers Enter into Wound Biologics Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Wound Biologics Sales by Type (2015-2020) (K MT)
Table 23. Global Wound Biologics Sales Share by Type (2015-2020)
Table 24. Global Wound Biologics Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Wound Biologics Revenue Share by Type (2015-2020)
Table 26. Wound Biologics Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Wound Biologics Sales by Application (2015-2020) (K MT)
Table 28. Global Wound Biologics Sales Share by Application (2015-2020)
Table 29. North America Wound Biologics Sales by Country (2015-2020) (K MT)
Table 30. North America Wound Biologics Sales Market Share by Country (2015-2020)
Table 31. North America Wound Biologics Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Wound Biologics Revenue Market Share by Country (2015-2020)
Table 33. North America Wound Biologics Sales by Type (2015-2020) (K MT)
Table 34. North America Wound Biologics Sales Market Share by Type (2015-2020)
Table 35. North America Wound Biologics Sales by Application (2015-2020) (K MT)
Table 36. North America Wound Biologics Sales Market Share by Application (2015-2020)
Table 37. Europe Wound Biologics Sales by Country (2015-2020) (K MT)
Table 38. Europe Wound Biologics Sales Market Share by Country (2015-2020)
Table 39. Europe Wound Biologics Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Wound Biologics Revenue Market Share by Country (2015-2020)
Table 41. Europe Wound Biologics Sales by Type (2015-2020) (K MT)
Table 42. Europe Wound Biologics Sales Market Share by Type (2015-2020)
Table 43. Europe Wound Biologics Sales by Application (2015-2020) (K MT)
Table 44. Europe Wound Biologics Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Wound Biologics Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Wound Biologics Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Wound Biologics Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Wound Biologics Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Wound Biologics Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Wound Biologics Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Wound Biologics Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Wound Biologics Sales Market Share by Application (2015-2020)
Table 53. Latin America Wound Biologics Sales by Country (2015-2020) (K MT)
Table 54. Latin America Wound Biologics Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Wound Biologics Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Wound Biologics Revenue Market Share by Country (2015-2020)
Table 57. Latin America Wound Biologics Sales by Type (2015-2020) (K MT)
Table 58. Latin America Wound Biologics Sales Market Share by Type (2015-2020)
Table 59. Latin America Wound Biologics Sales by Application (2015-2020) (K MT)
Table 60. Latin America Wound Biologics Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Wound Biologics Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Wound Biologics Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Wound Biologics Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Wound Biologics Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Wound Biologics Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Wound Biologics Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Wound Biologics Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Wound Biologics Sales Market Share by Application (2015-2020)
Table 69. Avita Medical Corporation Information
Table 70. Avita Medical Description and Major Businesses
Table 71. Avita Medical Wound Biologics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Avita Medical Product
Table 73. Avita Medical Recent Development
Table 74. ConvaTec Corporation Information
Table 75. ConvaTec Description and Major Businesses
Table 76. ConvaTec Wound Biologics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. ConvaTec Product
Table 78. ConvaTec Recent Development
Table 79. Acelity Corporation Information
Table 80. Acelity Description and Major Businesses
Table 81. Acelity Wound Biologics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Acelity Product
Table 83. Acelity Recent Development
Table 84. Cytori Therapeutic Corporation Information
Table 85. Cytori Therapeutic Description and Major Businesses
Table 86. Cytori Therapeutic Wound Biologics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Cytori Therapeutic Product
Table 88. Cytori Therapeutic Recent Development
Table 89. MacroCure Corporation Information
Table 90. MacroCure Description and Major Businesses
Table 91. MacroCure Wound Biologics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. MacroCure Product
Table 93. MacroCure Recent Development
Table 94. Nuo Therapeutics Corporation Information
Table 95. Nuo Therapeutics Description and Major Businesses
Table 96. Nuo Therapeutics Wound Biologics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Nuo Therapeutics Product
Table 98. Nuo Therapeutics Recent Development
Table 99. Molyncke Health Care Corporation Information
Table 100. Molyncke Health Care Description and Major Businesses
Table 101. Molyncke Health Care Wound Biologics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Molyncke Health Care Product
Table 103. Molyncke Health Care Recent Development
Table 104. Osiris Therapeutics Corporation Information
Table 105. Osiris Therapeutics Description and Major Businesses
Table 106. Osiris Therapeutics Wound Biologics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Osiris Therapeutics Product
Table 108. Osiris Therapeutics Recent Development
Table 109. Smith And Nephew Corporation Information
Table 110. Smith And Nephew Description and Major Businesses
Table 111. Smith And Nephew Wound Biologics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Smith And Nephew Product
Table 113. Smith And Nephew Recent Development
Table 114. Organogenesis Corporation Information
Table 115. Organogenesis Description and Major Businesses
Table 116. Organogenesis Wound Biologics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Organogenesis Product
Table 118. Organogenesis Recent Development
Table 119. Global Wound Biologics Sales Forecast by Regions (2021-2026) (K MT)
Table 120. Global Wound Biologics Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Wound Biologics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Wound Biologics Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Wound Biologics Sales Forecast by Country (2021-2026) (K MT)
Table 124. North America: Wound Biologics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Wound Biologics Sales Forecast by Country (2021-2026) (K MT)
Table 126. Europe: Wound Biologics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Wound Biologics Sales Forecast by Region (2021-2026) (K MT)
Table 128. Asia Pacific: Wound Biologics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Wound Biologics Sales Forecast by Country (2021-2026) (K MT)
Table 130. Latin America: Wound Biologics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Wound Biologics Sales Forecast by Country (2021-2026) (K MT)
Table 132. Middle East and Africa: Wound Biologics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Wound Biologics Players
Table 137. Wound Biologics Customers List
Table 138. Wound Biologics Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Wound Biologics Product Picture
Figure 2. Global Wound Biologics Sales Market Share by Type in 2020 & 2026
Figure 3. Skin Substitutes Product Picture
Figure 4. Growth Factors Product Picture
Figure 5. Global Wound Biologics Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Drugstore
Figure 8. Others
Figure 9. Wound Biologics Report Years Considered
Figure 10. Global Wound Biologics Market Size 2015-2026 (US$ Million)
Figure 11. Global Wound Biologics Sales 2015-2026 (K MT)
Figure 12. Global Wound Biologics Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Wound Biologics Sales Market Share by Region (2015-2020)
Figure 14. Global Wound Biologics Sales Market Share by Region in 2019
Figure 15. Global Wound Biologics Revenue Market Share by Region (2015-2020)
Figure 16. Global Wound Biologics Revenue Market Share by Region in 2019
Figure 17. Global Wound Biologics Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Wound Biologics Revenue in 2019
Figure 19. Wound Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Wound Biologics Sales Market Share by Type (2015-2020)
Figure 21. Global Wound Biologics Sales Market Share by Type in 2019
Figure 22. Global Wound Biologics Revenue Market Share by Type (2015-2020)
Figure 23. Global Wound Biologics Revenue Market Share by Type in 2019
Figure 24. Global Wound Biologics Market Share by Price Range (2015-2020)
Figure 25. Global Wound Biologics Sales Market Share by Application (2015-2020)
Figure 26. Global Wound Biologics Sales Market Share by Application in 2019
Figure 27. Global Wound Biologics Revenue Market Share by Application (2015-2020)
Figure 28. Global Wound Biologics Revenue Market Share by Application in 2019
Figure 29. North America Wound Biologics Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Wound Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Wound Biologics Sales Market Share by Country in 2019
Figure 32. North America Wound Biologics Revenue Market Share by Country in 2019
Figure 33. U.S. Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Wound Biologics Market Share by Type in 2019
Figure 38. North America Wound Biologics Market Share by Application in 2019
Figure 39. Europe Wound Biologics Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Wound Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Wound Biologics Sales Market Share by Country in 2019
Figure 42. Europe Wound Biologics Revenue Market Share by Country in 2019
Figure 43. Germany Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Wound Biologics Market Share by Type in 2019
Figure 54. Europe Wound Biologics Market Share by Application in 2019
Figure 55. Asia Pacific Wound Biologics Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Wound Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Wound Biologics Sales Market Share by Region in 2019
Figure 58. Asia Pacific Wound Biologics Revenue Market Share by Region in 2019
Figure 59. China Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Wound Biologics Market Share by Type in 2019
Figure 82. Asia Pacific Wound Biologics Market Share by Application in 2019
Figure 83. Latin America Wound Biologics Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Wound Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Wound Biologics Sales Market Share by Country in 2019
Figure 86. Latin America Wound Biologics Revenue Market Share by Country in 2019
Figure 87. Mexico Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Wound Biologics Market Share by Type in 2019
Figure 94. Latin America Wound Biologics Market Share by Application in 2019
Figure 95. Middle East and Africa Wound Biologics Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Wound Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Wound Biologics Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Wound Biologics Revenue Market Share by Country in 2019
Figure 99. Turkey Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Wound Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Wound Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Wound Biologics Market Share by Type in 2019
Figure 106. Middle East and Africa Wound Biologics Market Share by Application in 2019
Figure 107. North America Wound Biologics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Wound Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Wound Biologics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Wound Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Wound Biologics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Wound Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Wound Biologics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Wound Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Wound Biologics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Wound Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
皮膚・創傷消毒の世界市場（～2026年） Skin disinfection is a process used to reduce the level of microorganisms on the skin. Povidone iodine, chlorhexidine, and xitamax are some of the solutions that can be used to disinfect the skin. Market Analysis and Insights: Global Skin and Wound Disinfection Market The global Skin and Wound Disin…- 創傷組織分析ソリューションの世界市場（～2026年） Wound tissue analysis solutions are designed for tissue analysis of wounds to determine characterization and classification of wounds so as to determine the prognosis for optimum rate and degree of healing. Wound tissue analysis solutions detect parameters such as an array of pathogens, state of rec…
- 創傷洗浄の世界市場（～2026年） Market Analysis and Insights: Global Wound Cleaning Market The global Wound Cleaning market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Wound Cleaning Scope and Market Size Wound Cleaning market is segmented by Type, and …
- 高度創傷ケアの世界市場（～2026年） Advanced Wound Care products for the wound healing process are generally prescribed by clinicians after a visit to the doctor or hospital. Advanced Wound Care products generally includes film and foam dressings, hydrogels, alginates and hydrocolloids. Such products are largely focused on keeping the…
- 高度創傷管理技術の世界市場（～2026年） Advanced wound management refers to a process of using new techniques and therapies for healing wounds. Advanced wound management technologies help in faster healing and improve outcomes. On the basis of type of wound, advanced wound management technologies market can be segmented into acute wound, …